Compound Summary
Compound Information
药名: | cucurbitacin b |
别名: | Cucurbitacin; Cucurbitacine (B); acetic acid [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester; LMST01010104; NSC144154; 19-nor-9.beta.,10.alpha.-Lanosta-5,23-diene-3,11,22-trione, 9-methyl-2.beta.,16.alpha.,20,25-tetrahydroxy-, 25-acetate; C08794; NSC49451; [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; acetic acid [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohex-2-enyl] ester; Datisca principle B; [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate; acetic acid [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohex-2-enyl] ester; acetic acid [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester; [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate; 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (2.beta.,9.beta.,10.alpha.,16.alpha.,23E)-; [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-hept-3-en-2-yl] ethanoate; [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; Cucurbitacin B; Datiscn Principle B; [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-hept-3-en-2-yl] ethanoate; 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, [2.beta.,.gamma.,.beta.,10.alpha.,16.alpha.]-; NCI60_004184; 6199-67-3 |
分子式: | C32H46O8 |
Smiles: | CC(=O)OC(C)(C)C=CC(=O)C(C)(C1C(CC2(C1(CC(=O)C3(C2CC=C4C3CC(C(=O)C4(C)C)O)C)C)C)O)O |
成分: | HBIN021845;HBIN021843 |
OB_score: | 25.900014 |
CAS_id: | 6199-67-3 |
SymMap_id: | SMIT00503 |
TCMID_id: | 4316;33192 |
TCMSP_id: | MOL002440 |
PubChem_id: | 180751 |
化合物对应的植物
| 植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
|---|
| TCMBANKHE000658 | 黄瓜藤 | |||||
| TCMBANKHE000903 | 甜瓜皮 | |||||
| TCMBANKHE001333 | Semen Cucumis | 甜瓜子 | ||||
| TCMBANKHE001533 | 生瓜 | |||||
| TCMBANKHE001546 | 甜瓜叶 | |||||
| TCMBANKHE001778 | 甜瓜花 | |||||
| TCMBANKHE002686 | 黄瓜根 | |||||
| TCMBANKHE002902 | 黄瓜叶 | |||||
| TCMBANKHE003062 | 甜瓜根 | |||||
| TCMBANKHE003344 | Cucumis africanus | |||||
| TCMBANKHE003495 | 甜瓜茎 | |||||
| TCMBANKHE005846 | 青葙子 | 1. Hypotensive2. Celosiaol, one of its active components is a mydriatic. | ||||
| TCMBANKHE004526 | Rhizoma Bolbostemmae | 土贝母 | To dissolve lumps, cause subsidence of swelling, and counteract toxicity./Treatment of mastitis, chronic lymphadenitis, tuberculosis of cervical lymph nodes, hypertrophic rhinitis. | |||
| TCMBANKHE004709 | Begonia nantoensis | 南投秋海棠 | ||||
| TCMBANKHE004718 | Bryonia alba | 白泻根 | ||||
| TCMBANKHE007086 | Strophanthus divaricatus | 羊角坳子 | To quicken blood and disperse swelling, strengthen heart, kill worms and relieve itch./Wind-damp, scab and lichen, knocks and falls, swelling of sores, cardiac failure, rheumatic arthritis. | |||
| TCMBANKHE007551 | Catechu | 儿茶 | To reduce toxic and to remove dampness./To arrest exudation, promote the growth of new tissue, and cure wounds. | |||
| TCMBANKHE008763 | Ecballium elaterium | 喷瓜 | ||||
| TCMBANKHE008343 | Radix Trichosanthis | 天花粉 | To remove heat, to promote the production of body fluid, and to facilitate the drainage of pus and the subsidence of swelling./Febrile diseases thirst, lung heat dry cough, diabetes mellitus due to internal heat, toxin swelling of sores, induce abortion. | |||
| TCMBANKHE006991 | 胡黄连 | Steaming bone tidal fever due to yin vacuity, night sweating, child gan accumulation, indigestion, abdominal distention and emaciation, dysentery, fever, gastrointestinal damp-heat diarrhea, hemorrhoids. | ||||
| TCMBANKHE008443 | Hemsleya graciliflora [Syn. Alsomitra graciliflora] | 细花雪胆 | ||||
| TCMBANKHE006580 | Calycis Melo | 瓜蒂 | Vomiting promotion/Wind stroke, epilepsy, throat impediment, indigestion of overnight food, distending pain in stomach duct, damp-heat jaundice, chronic hepatitis, cirrhosis. | |||
| TCMBANKHE007029 | Citrullus colocynthis | 药西瓜 | ||||
| TCMBANKHE008507 | Iberis umbellata | 伞形屈曲花 | ||||
| TCMBANKHE008014 | Picria felterrae | 苦玄参 | To clear heat and resolve toxin, disperse swelling and relieve pain./Wind-heat common cold, swelling pain in throat, mumps, swollen boil, diarrhea and dysentery, hemorrhoids, eczema, poisonous snake bites, knocks and falls. | |||
| TCMBANKHE006421/YEM-1037/XU-804 | Trichosanthes kirilowii Maxim.|Trichosanthes kirilowii | 瓜蒌|栝楼 | 天花粉 | 云南民族药物志：第五卷|云南省昭通市盐津县 | Angina pectoris, lung heat cough, chest impediment, diabetes mellitus, acute mastitis, constipation, swelling toxin of welling abscess and sore. | 苗族/彝族 |
| TCMBANKHE006668/YEM-19 | Aquilaria sinensis|Aquilaria sinensis (Lour.) Spreng. | 白木香 | 沉香 | 云南民族药物志：第一卷 | See Aquilaria agallocha./See Aquilaria agallocha . | 阿昌族/傣族/德昂族/哈尼族/景颇族/傈僳族/彝族/藏族 |
| TCMBANKHE003533/YEM-213 | Retinervus Luffae Fructus|Luffa cylindrica(L.)Roem. | 丝瓜络|丝瓜 | 丝瓜 | 云南民族药物志：第二卷 | Treatment of arthralgia with muscular contracture, distension and pain in the chest and costal regions, galactostasis./Treatment of arthralgia with muscular contracture, distension and pain in the chest and costal regions, galactostasis. | 阿昌族/傣族/德昂族/景颇族/傈僳族/水族/彝族/藏族 |
| TCMBANKHE006143/YEM-213 | Luffa cylindrica|Luffa cylindrica(L.)Roem. | 丝瓜 | 丝瓜 | 云南民族药物志：第二卷 | To clear heat and resolve phlegm, cool blood and resolve toxin./Febrile diseases with vexation and thirst, cough of phlegm asthma, intestinal wind bleeding, bleeding from hemorrhoids, blood strangury, flooding and spotting, sores with welling abscess and flat abscess, galactostasis, innominate toxin swelling, edema. | 阿昌族/傣族/德昂族/景颇族/傈僳族/水族/彝族/藏族 |
| TCMBANKHE008177/YEM-315 | Lagenaria siceraria var. depressa|Lagenaria siceraria( Molina )Standl. | 瓠瓜|葫芦 | 葫芦 | 云南民族药物志：第二卷 | To disinhibit water, disperse swelling, free strangury, dissipate binds./Edema, ascites, jaundice, diabetes mellitus, strangury, swollen welling abscess. | 阿昌族/傣族/德昂族/景颇族/傈僳族/彝族/藏族 |
| TCMBANKHE006044/YEM-315 | Pericarpium lagenariae|Lagenaria siceraria( Molina )Standl. | 葫芦 | 葫芦 | 云南民族药物志：第二卷 | Treatment of edema. Calabash gourd (Hulu) is used with herbs which promote water metabolism, such as Benincasa peel (Dongguapi)./Treatment of edema. Calabash gourd (Hulu) is used with herbs which promote water metabolism, such as Benincasa peel (Dongguapi). | 阿昌族/傣族/德昂族/景颇族/傈僳族/彝族/藏族 |
| TCMBANKHE004426/YEM-669 | Cucumis sativus|Cucumis sativus L. | 黄瓜 | 黄瓜 | 云南民族药物志：第四卷 | To clear heat, disinhibit water, resolve toxin./Febrile diseases thirst, short voidings of reddish urine, burns and scalds, scant urine with edema, sweat macule, prickly heat. | 傣族/哈尼族/佤族/彝族 |
| TCMBANKHE008148/YEM-669 | Cucumis sativus|Cucumis sativus L. | 黄瓜 | 黄瓜 | 云南民族药物志：第四卷 | To clear heat, disinhibit water, resolve toxin./Febrile diseases thirst, short voidings of reddish urine, burns and scalds, scant urine with edema, sweat macule, prickly heat. | 傣族/哈尼族/佤族/彝族 |
| TCMBANKHE004517/YEM-793 | Hemsleya macrosperma|Hemsleya macrosperma C.Y.Wu ex C.Y.Wu et C.L.Chen. | 大籽雪胆|罗锅底 | 苦金盆 | 云南民族药物志：第四卷 | See Hemsleya amabilis./See Hemsleya amabilis. | 傣族/苗族/佤族 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
| TCMBANKDI000022 | Prostatic Neoplasms | group | Neoplasms; Male Urogenital Diseases | 24690568 |
| TCMBANKDI000047 | Neoplasm Metastasis | phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | 24994678 |
| TCMBANKDI000069 | Bone neoplasms | group | Neoplasms; Musculoskeletal Diseases | 21440986 |
| TCMBANKDI000070 | Osteosarcoma | disease | Neoplasms | 21440986 |
| TCMBANKDI000088 | Lung Neoplasms | group | Neoplasms; Respiratory Tract Diseases | 23340170 |
化合物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE000001 | CXCR2 | CD182; CDw128b; CMKAR2; IL8R2; IL8RA; IL8RB | C-X-C motif chemokine receptor 2 |
| TCMBANKGE000002 | CXCL3 | CINC-2b; GRO3; GROg; MIP-2b; MIP2B; SCYB3 | C-X-C motif chemokine ligand 3 |
| TCMBANKGE000072 | CXCL12 | IRH; PBSF; SCYB12; SDF1; TLSF; TPAR1 | C-X-C motif chemokine ligand 12 |
| TCMBANKGE000135 | CXCR4 | CD184; D2S201E; FB22; HM89; HSY3RR; LAP-3; LAP3; LCR1; LESTR; NPY3R; NPYR; NPYRL; NPYY3R; WHIM; WHIMS | C-X-C motif chemokine receptor 4 |
| TCMBANKGE000154 | CCR2 | CC-CKR-2; CCR-2; CCR2A; CCR2B; CD192; CKR2; CKR2A; CKR2B; CMKBR2; MCP-1-R | C-C motif chemokine receptor 2 |
| TCMBANKGE000168 | NR3C1 | GCCR; GCR; GCRST; GR; GRL | nuclear receptor subfamily 3 group C member 1 |
| TCMBANKGE000204 | CXCL8 | GCP-1; GCP1; IL8; LECT; LUCT; LYNAP; MDNCF; MONAP; NAF; NAP-1; NAP1; SCYB8 | C-X-C motif chemokine ligand 8 |
| TCMBANKGE000219 | CCR5 | CC-CKR-5; CCCKR5; CCR-5; CD195; CKR-5; CKR5; CMKBR5; IDDM22 | C-C motif chemokine receptor 5 |
| TCMBANKGE000224 | AGT | ANHU; SERPINA8; hFLT1 | angiotensinogen |
| TCMBANKGE000242 | SAA1 | PIG4; SAA; SAA2; TP53I4 | serum amyloid A1 |
| TCMBANKGE000332 | CCL20 | CKb4; Exodus; LARC; MIP-3-alpha; MIP-3a; MIP3A; SCYA20; ST38 | C-C motif chemokine ligand 20 |
| TCMBANKGE000333 | CCR6 | BN-1; C-C CKR-6; CC-CKR-6; CCR-6; CD196; CKR-L3; CKRL3; CMKBR6; DCR2; DRY6; GPR29; GPRCY4; STRL22 | C-C motif chemokine receptor 6 |
| TCMBANKGE000354 | FPR2 | ALXR; FMLP-R-II; FMLPX; FPR2A; FPRH1; FPRH2; FPRL1; HM63; LXA4R | formyl peptide receptor 2 |
| TCMBANKGE000394 | CXCR3 | CD182; CD183; CKR-L2; CMKAR3; GPR9; IP10-R; Mig-R; MigR | C-X-C motif chemokine receptor 3 |
| TCMBANKGE000395 | CXCL9 | CMK; Humig; MIG; SCYB9; crg-10 | C-X-C motif chemokine ligand 9 |
| TCMBANKGE000408 | CCR3 | C C CKR3; CC-CKR-3; CD193; CKR 3; CKR3; CMKBR3 | C-C motif chemokine receptor 3 |
| TCMBANKGE000409 | CCR4 | CC-CKR-4; CD194; CKR4; CMKBR4; ChemR13; HGCN:14099; K5-5 | C-C motif chemokine receptor 4 |
| TCMBANKGE000465 | CASR | CAR; EIG8; FHH; FIH; GPRC2A; HHC; HHC1; HYPOC1; NSHPT; PCAR1; hCasR | calcium sensing receptor |
| TCMBANKGE000471 | POMC | ACTH; CLIP; LPH; MSH; NPP; OBAIRH; POC | proopiomelanocortin |
| TCMBANKGE000509 | GPR55 | LPIR1 | G protein-coupled receptor 55 |
| TCMBANKGE000514 | CNR1 | CANN6; CB-R; CB1; CB1A; CB1K5; CB1R; CNR | cannabinoid receptor 1 |
| TCMBANKGE000518 | GPER1 | CEPR; CMKRL2; DRY12; FEG-1; GPCR-Br; GPER; GPR30; LERGU; LERGU2; LyGPR; mER | G protein-coupled estrogen receptor 1 |
| TCMBANKGE000544 | CXCR1 | C-C; C-C-CKR-1; CD128; CD181; CDw128a; CKR-1; CMKAR1; IL8R1; IL8RA; IL8RBA | C-X-C motif chemokine receptor 1 |
| TCMBANKGE000545 | CXCL2 | CINC-2a; GRO2; GROb; MGSA-b; MIP-2a; MIP2; MIP2A; SCYB2 | C-X-C motif chemokine ligand 2 |
| TCMBANKGE000555 | SST | SMST | somatostatin |
| TCMBANKGE000623 | CCL27 | ALP; CTACK; CTAK; ESKINE; ILC; PESKY; SCYA27 | C-C motif chemokine ligand 27 |
| TCMBANKGE000753 | CNR2 | CB-2; CB2; CX5 | cannabinoid receptor 2 |
| TCMBANKGE000801 | HTR1A | 5-HT-1A; 5-HT1A; 5HT1a; ADRB2RL1; ADRBRL1; G-21; PFMCD | 5-hydroxytryptamine receptor 1A |
| TCMBANKGE000835 | APP | AAA; ABETA; ABPP; AD1; APPI; CTFgamma; CVAP; PN-II; PN2; preA4 | amyloid beta precursor protein |
| TCMBANKGE000869 | DRD2 | D2DR; D2R | dopamine receptor D2 |
| TCMBANKGE000921 | CCNB1 | CCNB | cyclin B1 |
| TCMBANKGE001068 | CXCL1 | FSP; GRO1; GROa; MGSA; MGSA-a; NAP-3; SCYB1 | C-X-C motif chemokine ligand 1 |
| TCMBANKGE001119 | S1PR1 | CD363; CHEDG1; D1S3362; ECGF1; EDG-1; EDG1; S1P1 | sphingosine-1-phosphate receptor 1 |
| TCMBANKGE001166 | BCL2 | Bcl-2; PPP1R50 | BCL2 apoptosis regulator |
| TCMBANKGE001178 | STAT3 | ADMIO; ADMIO1; APRF; HIES | signal transducer and activator of transcription 3 |
| TCMBANKGE001188 | CXCL10 | C7; IFI10; INP10; IP-10; SCYB10; crg-2; gIP-10; mob-1 | C-X-C motif chemokine ligand 10 |
| TCMBANKGE001194 | ADRA2A | ADRA2; ADRA2R; ADRAR; ALPHA2AAR; ZNF32 | adrenoceptor alpha 2A |
| TCMBANKGE001195 | RXFP3 | GPCR135; RLN3R1; RXFPR3; SALPR | relaxin family peptide receptor 3 |
| TCMBANKGE001220 | TAS2R46 | T2R46; T2R54 | taste 2 receptor member 46 |
| TCMBANKGE001317 | FPR1 | FMLP; FPR | formyl peptide receptor 1 |
| TCMBANKGE001354 | CXCL13 | ANGIE; ANGIE2; BCA-1; BCA1; BLC; BLR1L; SCYB13 | C-X-C motif chemokine ligand 13 |
| TCMBANKGE001417 | HTR1E | 5-HT1E | 5-hydroxytryptamine receptor 1E |
| TCMBANKGE001833 | GRM3 | GLUR3; GPRC1C; MGLUR3; mGlu3 | glutamate metabotropic receptor 3 |
| TCMBANKGE001861 | BDKRB1 | B1BKR; B1R; BDKRB2; BKB1R; BKR1; BRADYB1 | bradykinin receptor B1 |
| TCMBANKGE001978 | GRM2 | GLUR2; GPRC1B; MGLUR2; mGlu2 | glutamate metabotropic receptor 2 |
| TCMBANKGE001995 | CCL19 | CKb11; ELC; MIP-3b; MIP3B; SCYA19 | C-C motif chemokine ligand 19 |
| TCMBANKGE002041 | GRM4 | GPRC1D; MGLUR4; mGlu4 | glutamate metabotropic receptor 4 |
| TCMBANKGE002264 | ACKR3 | CMKOR1; CXC-R7; CXCR-7; CXCR7; GPR159; RDC-1; RDC1 | atypical chemokine receptor 3 |
| TCMBANKGE002271 | CCR10 | GPR2 | C-C motif chemokine receptor 10 |
| TCMBANKGE002281 | GNAI2 | GIP; GNAI2B; H_LUCA15.1; H_LUCA16.1 | G protein subunit alpha i2 |
| TCMBANKGE002321 | SSTR1 | SRIF-2; SS-1-R; SS1-R; SS1R | somatostatin receptor 1 |
| TCMBANKGE002342 | GNAI3 | 87U6; ARCND1 | G protein subunit alpha i3 |
| TCMBANKGE002377 | CXCR5 | BLR1; CD185; MDR15 | C-X-C motif chemokine receptor 5 |
| TCMBANKGE002391 | LPAR3 | EDG7; Edg-7; GPCR; HOFNH30; LP-A3; LPA3; RP4-678I3 | lysophosphatidic acid receptor 3 |
| TCMBANKGE002437 | MTRNR2L12 | HN12 | MT-RNR2 like 12 |
| TCMBANKGE002494 | PENK | PE; PENK-A | proenkephalin |
| TCMBANKGE002567 | OXGR1 | GPR80; GPR99; P2RY15; P2Y15; aKGR | oxoglutarate receptor 1 |
| TCMBANKGE002688 | HTR1F | 5-HT-1F; 5-HT1F; 5HT6; HTR1EL; MR77 | 5-hydroxytryptamine receptor 1F |
| TCMBANKGE002708 | CCL28 | CCK1; MEC; SCYA28 | C-C motif chemokine ligand 28 |
| TCMBANKGE002834 | HEBP1 | HBP; HEBP | heme binding protein 1 |
| TCMBANKGE002842 | TAS2R30 | T2R30; T2R47; TAS2R47 | taste 2 receptor member 30 |
| TCMBANKGE002936 | GAL | ETL8; GAL-GMAP; GALN; GLNN; GMAP | galanin and GMAP prepropeptide |
| TCMBANKGE003055 | CCL21 | 6Ckine; CKb9; ECL; SCYA21; SLC; TCA4 | C-C motif chemokine ligand 21 |
| TCMBANKGE003157 | CHRM2 | HM2 | cholinergic receptor muscarinic 2 |
| TCMBANKGE003313 | SSTR5 | SS-5-R | somatostatin receptor 5 |
| TCMBANKGE003364 | CCL25 | Ckb15; SCYA25; TECK | C-C motif chemokine ligand 25 |
| TCMBANKGE003459 | TAS2R50 | T2R50; T2R51; TAS2R51 | taste 2 receptor member 50 |
| TCMBANKGE003528 | NPW | L8; L8C; PPL8; PPNPW | neuropeptide W |
| TCMBANKGE003592 | TAS2R14 | T2R14; TRB1 | taste 2 receptor member 14 |
| TCMBANKGE003816 | S1PR3 | EDG-3; EDG3; LPB3; S1P3 | sphingosine-1-phosphate receptor 3 |
| TCMBANKGE003874 | CXCR6 | BONZO; CD186; STRL33; TYMSTR | C-X-C motif chemokine receptor 6 |
| TCMBANKGE003910 | NPY4R2 | CH17-360D5.1; NPY4-R; NPY4R; PP1; PPYR1 | neuropeptide Y receptor Y4-2 |
| TCMBANKGE004055 | SSTR4 | SS-4-R; SS4-R; SS4R | somatostatin receptor 4 |
| TCMBANKGE004284 | HCAR3 | GPR109B; HCA3; HM74; PUMAG; Puma-g | hydroxycarboxylic acid receptor 3 |
| TCMBANKGE004391 | MTNR1B | FGQTL2; MEL-1B-R; MT2 | melatonin receptor 1B |
| TCMBANKGE004408 | HCAR2 | GPR109A; HCA2; HM74a; HM74b; NIACR1; PUMAG; Puma-g | hydroxycarboxylic acid receptor 2 |
| TCMBANKGE004421 | KNG1 | BDK; BK; HMWK; KNG | kininogen 1 |
| TCMBANKGE004548 | CCR9 | CC-CKR-9; CDw199; GPR-9-6; GPR28 | C-C motif chemokine receptor 9 |
| TCMBANKGE004795 | TAS2R8 | T2R8; TRB5 | taste 2 receptor member 8 |
| TCMBANKGE004828 | HRH3 | GPCR97; HH3R | histamine receptor H3 |
| TCMBANKGE005056 | NPBWR2 | GPR8 | neuropeptides B and W receptor 2 |
| TCMBANKGE005122 | FPR3 | FML2_HUMAN; FMLP-R-II; FMLPY; FPRH1; FPRH2; FPRL2; RMLP-R-I | formyl peptide receptor 3 |
| TCMBANKGE005132 | GRM8 | GLUR8; GPRC1H; MGLUR8; mGlu8 | glutamate metabotropic receptor 8 |
| TCMBANKGE005265 | GPR17 | - | G protein-coupled receptor 17 |
| TCMBANKGE005288 | PDYN | ADCA; PENKB; SCA23 | prodynorphin |
| TCMBANKGE005291 | TAS2R31 | T2R31; T2R44; T2R53; TAS2R44 | taste 2 receptor member 31 |
| TCMBANKGE005406 | CCR1 | CD191; CKR-1; CKR1; CMKBR1; HM145; MIP1aR; SCYAR1 | C-C motif chemokine receptor 1 |
| TCMBANKGE005508 | LPAR5 | GPR92; GPR93; KPG_010; LPA5 | lysophosphatidic acid receptor 5 |
| TCMBANKGE005634 | PPBP | B-TG1; Beta-TG; CTAP-III; CTAP3; CTAPIII; CXCL7; LA-PF4; LDGF; MDGF; NAP-2; PBP; SCYB7; TC1; TC2; TGB; TGB1; THBGB; THBGB1 | pro-platelet basic protein |
| TCMBANKGE005777 | AGTR2 | AT2; ATGR2; MRX88 | angiotensin II receptor type 2 |
| TCMBANKGE005975 | ADORA1 | RDC7 | adenosine A1 receptor |
| TCMBANKGE006055 | MCHR1 | GPR24; MCH-1R; MCH1R; SLC-1; SLC1 | melanin concentrating hormone receptor 1 |
| TCMBANKGE006079 | NMUR2 | FM-4; FM4; NMU-R2; NMU2R; TGR-1; TGR1 | neuromedin U receptor 2 |
| TCMBANKGE006096 | GALR3 | - | galanin receptor 3 |
| TCMBANKGE006105 | NMS | - | neuromedin S |
| TCMBANKGE006256 | P2RY14 | BPR105; GPR105; P2Y14 | purinergic receptor P2Y14 |
| TCMBANKGE006488 | TAS2R5 | T2R5 | taste 2 receptor member 5 |
| TCMBANKGE006565 | NPY | PYY4 | neuropeptide Y |
| TCMBANKGE006869 | PTGER3 | EP3; EP3-I; EP3-II; EP3-III; EP3-IV; EP3-VI; EP3e; PGE2-R; lnc003875 | prostaglandin E receptor 3 |
| TCMBANKGE007224 | GNAI1 | Gi | G protein subunit alpha i1 |
| TCMBANKGE007274 | GNAT3 | GDCA | G protein subunit alpha transducin 3 |
| TCMBANKGE007355 | MTNR1A | MEL-1A-R; MT1 | melatonin receptor 1A |
| TCMBANKGE007635 | NMUR1 | (FM-3); FM-3; FM3; GPC-R; GPR66; NMU1R | neuromedin U receptor 1 |
| TCMBANKGE007680 | S1PR4 | EDG6; LPC1; S1P4; SLP4 | sphingosine-1-phosphate receptor 4 |
| TCMBANKGE007713 | LPAR1 | EDG2; GPR26; Gpcr26; LPA1; Mrec1.3; VZG1; edg-2; rec.1.3; vzg-1 | lysophosphatidic acid receptor 1 |
| TCMBANKGE007721 | C5 | C5D; C5a; C5b; CPAMD4; ECLZB | complement C5 |
| TCMBANKGE007916 | TAS2R1 | T2R1; TRB7 | taste 2 receptor member 1 |
| TCMBANKGE007985 | GPR18 | - | G protein-coupled receptor 18 |
| TCMBANKGE008037 | TAS2R43 | T2R43; T2R52 | taste 2 receptor member 43 |
| TCMBANKGE008056 | ADRA2C | ADRA2L2; ADRA2RL2; ADRARL2; ALPHA2CAR | adrenoceptor alpha 2C |
| TCMBANKGE008640 | P2RY4 | NRU; P2P; P2Y4; UNR | pyrimidinergic receptor P2Y4 |
| TCMBANKGE008702 | OPRM1 | LMOR; M-OR-1; MOP; MOR; MOR1; OPRM | opioid receptor mu 1 |
| TCMBANKGE008733 | TAS2R9 | T2R9; TRB6 | taste 2 receptor member 9 |
| TCMBANKGE008743 | OPRK1 | K-OR-1; KOP; KOR; KOR-1; KOR1; OPRK | opioid receptor kappa 1 |
| TCMBANKGE008845 | GALR1 | GALNR; GALNR1 | galanin receptor 1 |
| TCMBANKGE008850 | TAS2R4 | T2R4 | taste 2 receptor member 4 |
| TCMBANKGE008878 | TAS2R13 | T2R13; TRB3 | taste 2 receptor member 13 |
| TCMBANKGE009346 | TAS2R20 | T2R20; T2R49; T2R56; TAS2R49 | taste 2 receptor member 20 |
| TCMBANKGE009387 | TAS2R19 | MSTP058; T2R19; T2R23; T2R48; TAS2R23; TAS2R48 | taste 2 receptor member 19 |
| TCMBANKGE009476 | NPY5R | NPY5-R; NPYR5; NPYY5-R | neuropeptide Y receptor Y5 |
| TCMBANKGE009562 | C5AR1 | C5A; C5AR; C5R1; CD88 | complement C5a receptor 1 |
| TCMBANKGE009590 | TAS2R39 | T2R39; T2R57 | taste 2 receptor member 39 |
| TCMBANKGE009707 | GALR2 | GAL2-R; GALNR2; GALR-2 | galanin receptor 2 |
| TCMBANKGE009871 | GRM6 | CSNB1B; GPRC1F; MGLUR6; mGlu6 | glutamate metabotropic receptor 6 |
| TCMBANKGE009942 | TAS2R16 | BGLPT; T2R16 | taste 2 receptor member 16 |
| TCMBANKGE009958 | NPB | L7; PPL7; PPNPB | neuropeptide B |
| TCMBANKGE009981 | GRM7 | GLUR7; GPRC1G; MGLU7; MGLUR7; PPP1R87 | glutamate metabotropic receptor 7 |
| TCMBANKGE010210 | S1PR5 | EDG8; Edg-8; S1P5; SPPR-1; SPPR-2 | sphingosine-1-phosphate receptor 5 |
| TCMBANKGE010234 | CXCL6 | CKA-3; GCP-2; GCP2; SCYB6 | C-X-C motif chemokine ligand 6 |
| TCMBANKGE010350 | CCR7 | BLR2; CC-CKR-7; CCR-7; CD197; CDw197; CMKBR7; EBI1 | C-C motif chemokine receptor 7 |
| TCMBANKGE010398 | MCHR2 | GPR145; GPRv17; MCH-2R; MCH-R2; MCH2; MCH2R; MCHR-2; SLT | melanin concentrating hormone receptor 2 |
| TCMBANKGE010482 | C3AR1 | AZ3B; C3AR; HNFAG09 | complement C3a receptor 1 |
| TCMBANKGE010518 | TAS2R7 | T2R7; TRB4 | taste 2 receptor member 7 |
| TCMBANKGE010579 | NPY1R | NPY1-R; NPYR | neuropeptide Y receptor Y1 |
| TCMBANKGE010680 | RXFP4 | GPCR142; GPR100; RLN3R2; RXFPR4 | relaxin family peptide/INSL5 receptor 4 |
| TCMBANKGE011045 | TMIGD3 | AD026 | transmembrane and immunoglobulin domain containing 3 |
| TCMBANKGE011106 | TAS2R40 | GPR60; T2R40; T2R58 | taste 2 receptor member 40 |
| TCMBANKGE011132 | TAS2R3 | T2R3 | taste 2 receptor member 3 |
| TCMBANKGE011213 | P2RY12 | ADPG-R; BDPLT8; HORK3; P2T(AC); P2Y(12)R; P2Y(AC); P2Y(ADP); P2Y(cyc); P2Y12; SP1999 | purinergic receptor P2Y12 |
| TCMBANKGE011322 | TAS2R41 | T2R41; T2R59 | taste 2 receptor member 41 |
| TCMBANKGE011385 | APLNR | AGTRL1; APJ; APJR; HG11 | apelin receptor |
| TCMBANKGE011401 | S1PR2 | AGR16; DFNB68; EDG-5; EDG5; Gpcr13; H218; LPB2; S1P2 | sphingosine-1-phosphate receptor 2 |
| TCMBANKGE011638 | TAS2R42 | T2R24; T2R42; T2R55; TAS2R55 | taste 2 receptor member 42 |
| TCMBANKGE011681 | CXCL16 | CXCLG16; SR-PSOX; SRPSOX | C-X-C motif chemokine ligand 16 |
| TCMBANKGE011860 | NPBWR1 | GPR7 | neuropeptides B and W receptor 1 |
| TCMBANKGE011908 | TAS2R10 | T2R10; TRB2 | taste 2 receptor member 10 |
| TCMBANKGE011923 | CHRM4 | HM4; M4R | cholinergic receptor muscarinic 4 |
| TCMBANKGE011926 | CXCL11 | H174; I-TAC; IP-9; IP9; SCYB11; SCYB9B; b-R1 | C-X-C motif chemokine ligand 11 |
| TCMBANKGE011928 | CCR8 | CC-CKR-8; CCR-8; CDw198; CKRL1; CMKBR8; CMKBRL2; CY6; GPRCY6; TER1 | C-C motif chemokine receptor 8 |
| TCMBANKGE012345 | DRD3 | D3DR; ETM1; FET1 | dopamine receptor D3 |
| TCMBANKGE012438 | NPY2R | NPY2-R | neuropeptide Y receptor Y2 |
| TCMBANKGE012889 | OPRL1 | KOR-3; KOR3; NOCIR; NOP; NOPr; OOR; OPRL; ORL1 | opioid related nociceptin receptor 1 |
| TCMBANKGE012982 | HTR5A | 5-HT5A | 5-hydroxytryptamine receptor 5A |
| TCMBANKGE013032 | NMU | - | neuromedin U |
| TCMBANKGE013093 | OXER1 | GPCR; GPR170; TG1019 | oxoeicosanoid receptor 1 |
| TCMBANKGE013226 | DRD4 | D4DR | dopamine receptor D4 |
| TCMBANKGE013345 | P2RY13 | FKSG77; GPCR1; GPR86; GPR94; P2Y13; SP174 | purinergic receptor P2Y13 |
| TCMBANKGE013564 | PYY | PYY-I; PYY1 | peptide YY |
| TCMBANKGE013591 | PNOC | N/OFQ; NOP; OFQ; PPNOC; ppN/OFQ | prepronociceptin |
| TCMBANKGE013621 | SUCNR1 | GPR91 | succinate receptor 1 |
| TCMBANKGE013691 | CXCL5 | ENA-78; SCYB5 | C-X-C motif chemokine ligand 5 |
| TCMBANKGE013819 | PMCH | MCH; ppMCH | pro-melanin concentrating hormone |
| TCMBANKGE013931 | PPY | PNP; PP | pancreatic polypeptide |
| TCMBANKGE014106 | LPAR2 | EDG-4; EDG4; LPA-2; LPA2 | lysophosphatidic acid receptor 2 |
| TCMBANKGE014110 | C3 | AHUS5; ARMD9; ASP; C3a; C3b; CPAMD1; HEL-S-62p | complement C3 |
| TCMBANKGE014167 | TAS2R60 | T2R56; T2R60 | taste 2 receptor member 60 |
| TCMBANKGE014188 | HRH4 | AXOR35; BG26; GPCR105; GPRv53; H4; H4R; HH4R | histamine receptor H4 |
| TCMBANKGE014381 | PTGDR2 | CD294; CRTH2; DL1R; DP2; GPR44 | prostaglandin D2 receptor 2 |
| TCMBANKGE014438 | TAS2R38 | PTC; T2R38; T2R61; THIOT | taste 2 receptor member 38 |
| TCMBANKGE014557 | ANXA1 | ANX1; LPC1 | annexin A1 |
| TCMBANKGE014563 | GNG2 | - | G protein subunit gamma 2 |
| TCMBANKGE014625 | OPRD1 | DOP; DOR; DOR1; OPRD | opioid receptor delta 1 |
| TCMBANKGE014812 | SSTR2 | - | somatostatin receptor 2 |
| TCMBANKGE014869 | HTR1B | 5-HT-1B; 5-HT-1D-beta; 5-HT1B; 5-HT1DB; HTR1D2; HTR1DB; S12 | 5-hydroxytryptamine receptor 1B |
滇ICP备16009434号-1 |
Dai SX Lab